Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance
- Conditions
- HepatectomyLaparoscopy
- Registration Number
- NCT06044909
- Brief Summary
Multimodal intraoperative minimal-invasive (laparoscopic or robotic) liver surgery images will be registered to each other. Explicitly, these are the ultrasound and laparoscope images. Once they are registered, they will reveal the hidden tumor's location to the surgeon in real time through augmented reality. The intraoperative augmentation will also be enriched with the preoperative data (e.g., CT or MRI). This will simplify minimal invasive liver surgery, improve surgical safety and accuracy. It will also shorten hospital stays and contribute to an overall better quality of life for the patient, which in return will reduce the health-care costs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
- Patients undergoing hepatectomy;
- Patients for whom good-quality imaging is available (CT scan and/or MRI and/or ultrasound);
- Patients over 18 years of age;
- Minimally invasive surgery by conventional or robot-assisted laparoscopy.
- Surgery by laparotomy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis accuracy of the augmented reality by aligned with the intraoperative measurements 28 months The accuracy of the augmented reality will be assessed based on how well the preoperative data will be aligned with the intraoperative measurements. In order to assess the accuracy, measurements of multiple distances between the center of mass (mean position) of different internal structures (tumors, anatomical vascular networks, anatomical landmarks) visible both in the preoperative imaging and in the intraoperative imaging will be used.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
CHU Saint Etienne
🇫🇷Saint-Étienne, France
CHU Saint Etienne🇫🇷Saint-Étienne, FranceBertrand LE ROY, MD PhDContact(0)477120508bertrand.leroy@chu-st-etienne.fr